- Nachrichtendetail
-
03.07.2024 07:11:42 - dpa-AFX: *REGENERON: EC APPROVES DUPIXENT AS ADD-ON MAINTENANCE TREATMENT FOR ADULTS WITH COPD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.096,520 | 16.07.24 20:53:09 | +14,410 | +1,33% | 1.096,210 | 1.098,020 | 1.097,290 | 1.082,110 |
